Risk factors associated with inhibitor development in Chinese patients with haemophilia B-Reference-Cited by-同舟云学术

Risk factors associated with inhibitor development in Chinese patients with haemophilia B

Published:2015-04-30 Issue:4 Volume:21 Page:e286-e293
ISSN:1351-8216
Container-title:Haemophilia
language:en
Short-container-title:Haemophilia

Author:

Zhou J.¹,Ding Q.²,Chen Z.³,Yang H.⁴,Lin L.²,Wang H.¹,Wang X.²,Wu R.³

Affiliation:

1. State Key Laboratory of Medical Genomics; Shanghai Institute of Hematology; Ruijin Hospital; Shanghai Jiaotong University School of Medicine; Shanghai China

2. Department of Laboratory Medicine; Ruijin Hospital; Shanghai Jiaotong University School of Medicine; Shanghai China

3. Hematology-Oncology Center; Beijing Children's Hospital; Capital Medical University; Beijing China

4. Department of Hemotology; Xiangya Hospital; Central South University; Changsha China

Funder

National Basic Research Program of China

Youth Program of National Natural Science Foundation of China

General Program of National Natural Science Foundation of China

Publisher

Wiley

Subject

Genetics(clinical),Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hae.12684/fullpdf

Reference33 articles.

1. The Pennsylvania hemophilia program 1973-1978;Eyster;Am J Hematol,1980

2. Inhibitor development in haemophilia B: an orphan disease in need of attention;DiMichele;Br J Haematol,2007

3. Inhibitors in factor IX deficiency a report of the ISTH-SSC international FIX inhibitor registry (1997-2006);Chitlur;Haemophilia,2009

4. Nephrotic syndrome as a complication of immune tolerance in hemophilia B;Ewenstein;Blood,1997

5. Incidence of factor VIII inhibitors in severe haemophilia: the importance of patient age;Lorenzo;Br J Haematol,2001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Genetic and Non-Genetic Factors Related to the Development of Hemophilia Inhibitors;Advances in Clinical Medicine;2024

2. Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China;Haemophilia;2022-09-26

3. Generation an induced pluripotent stem cell line SXMUi001-A derived from a hemophilia B patient carries variant F9 c.223C＞T(p.R75X);Stem Cell Research;2022-04

4. Polymorphisms in MAPK9 (rs4147385) and CSF1R (rs17725712) are associated with the development of inhibitors in patients with haemophilia A in North China;International Journal of Laboratory Hematology;2019-05-31

5. Intracranial hemorrhage in congenital bleeding disorders;Blood Coagulation & Fibrinolysis;2018-01